378 related articles for article (PubMed ID: 27187366)
1. Hepcidin-Induced Iron Deficiency Is Related to Transient Anemia and Hypoferremia in Kawasaki Disease Patients.
Huang YH; Kuo HC; Huang FC; Yu HR; Hsieh KS; Yang YL; Sheen JM; Li SC; Kuo HC
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187366
[TBL] [Abstract][Full Text] [Related]
2. Inflammation-induced hepcidin is associated with the development of anemia and coronary artery lesions in Kawasaki disease.
Kuo HC; Yang YL; Chuang JH; Tiao MM; Yu HR; Huang LT; Yang KD; Chang WC; Lee CP; Huang YH
J Clin Immunol; 2012 Aug; 32(4):746-52. PubMed ID: 22392047
[TBL] [Abstract][Full Text] [Related]
3. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.
Kuo HC; Lo MH; Hsieh KS; Guo MM; Huang YH
PLoS One; 2015; 10(12):e0144603. PubMed ID: 26658843
[TBL] [Abstract][Full Text] [Related]
4. Hepcidin in Kawasaki disease: upregulation by acute inflammation in patients having resistance to intravenous immunoglobulin therapy.
Ishikawa T; Wada Y; Namba H; Kawai T
Clin Rheumatol; 2021 Dec; 40(12):5019-5024. PubMed ID: 34148165
[TBL] [Abstract][Full Text] [Related]
5. Anemia in Kawasaki Disease: Hepcidin as a Potential Biomarker.
Huang YH; Kuo HC
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28417923
[TBL] [Abstract][Full Text] [Related]
6. Serum hepcidin concentrations correlate with ferritin in patients with inflammatory bowel disease.
Mecklenburg I; Reznik D; Fasler-Kan E; Drewe J; Beglinger C; Hruz P;
J Crohns Colitis; 2014 Nov; 8(11):1392-7. PubMed ID: 24825446
[TBL] [Abstract][Full Text] [Related]
7. Hepcidin in tumor-related iron deficiency anemia and tumor-related anemia of chronic disease: pathogenic mechanisms and diagnosis.
Shu T; Jing C; Lv Z; Xie Y; Xu J; Wu J
Eur J Haematol; 2015 Jan; 94(1):67-73. PubMed ID: 24954786
[TBL] [Abstract][Full Text] [Related]
8. Association of lower eosinophil-related T helper 2 (Th2) cytokines with coronary artery lesions in Kawasaki disease.
Kuo HC; Wang CL; Liang CD; Yu HR; Huang CF; Wang L; Hwang KP; Yang KD
Pediatr Allergy Immunol; 2009 May; 20(3):266-72. PubMed ID: 19438983
[TBL] [Abstract][Full Text] [Related]
9. HAMP promoter hypomethylation and increased hepcidin levels as biomarkers for Kawasaki disease.
Huang YH; Kuo HC; Li SC; Cai XY; Liu SF; Kuo HC
J Mol Cell Cardiol; 2018 Apr; 117():82-87. PubMed ID: 29501389
[TBL] [Abstract][Full Text] [Related]
10. Hepcidin and proinflammatory markers in children with chronic kidney disease: A case-control study
.
Goyal KK; Saha A; Sahi PK; Kaur M; Dubey NK; Goyal P; Upadhayay AD
Clin Nephrol; 2018 May; 89(5):363-370. PubMed ID: 29451472
[TBL] [Abstract][Full Text] [Related]
11. Serum Hepcidin to Prohepcidin Ratio in Children with Iron Deficiency Anemia.
Chun S; Jeon JS; Lee MJ
Ann Clin Lab Sci; 2019 Sep; 49(5):639-644. PubMed ID: 31611207
[TBL] [Abstract][Full Text] [Related]
12. [Changes of serum 25-hydroxyvitamin D3 and interleukin-6 after treatment with intravenous immunoglobulins in children with Kawasaki disease].
Chen Y; Li W
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jul; 34(8):1230-2. PubMed ID: 25176105
[TBL] [Abstract][Full Text] [Related]
13. Maternal and Cord Blood Hepcidin Concentrations in Severe Iron Deficiency Anemia.
Basu S; Kumar N; Srivastava R; Kumar A
Pediatr Neonatol; 2016 Oct; 57(5):413-419. PubMed ID: 26922566
[TBL] [Abstract][Full Text] [Related]
14. TNF-α is superior to conventional inflammatory mediators in forecasting IVIG nonresponse and coronary arteritis in Chinese children with Kawasaki disease.
Hu P; Jiang GM; Wu Y; Huang BY; Liu SY; Zhang DD; Xu Y; Wu YF; Xia X; Wei W; Hu B
Clin Chim Acta; 2017 Aug; 471():76-80. PubMed ID: 28526535
[TBL] [Abstract][Full Text] [Related]
15. [Changes of P-selectin and E-selectin in children with Kawasaki disease].
Qiu Y; Wu J; Fang XY; Lin Z; Wu BY; Cai RY; Xu XY; Zheng H
Zhonghua Er Ke Za Zhi; 2004 Sep; 42(9):688-92. PubMed ID: 15482673
[TBL] [Abstract][Full Text] [Related]
16. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.
Tse SM; Silverman ED; McCrindle BW; Yeung RS
J Pediatr; 2002 Apr; 140(4):450-5. PubMed ID: 12006960
[TBL] [Abstract][Full Text] [Related]
17. IL-31 associated with coronary artery lesion formation in Kawasaki disease.
Tseng WN; Lo MH; Guo MM; Hsieh KS; Chang WC; Kuo HC
PLoS One; 2014; 9(8):e105195. PubMed ID: 25122210
[TBL] [Abstract][Full Text] [Related]
18. Aberrantly decreased levels of NKG2D expression in children with kawasaki disease.
Ge X; Li CR; Yang J; Wang GB
Scand J Immunol; 2013 May; 77(5):389-97. PubMed ID: 23298273
[TBL] [Abstract][Full Text] [Related]
19. Elevated D-dimer level is a risk factor for coronary artery lesions accompanying intravenous immunoglobulin-unresponsive Kawasaki disease.
Masuzawa Y; Mori M; Hara T; Inaba A; Oba MS; Yokota S
Ther Apher Dial; 2015 Apr; 19(2):171-7. PubMed ID: 25257673
[TBL] [Abstract][Full Text] [Related]
20. [Expression of sICAM-1 in children with intravenous immunoglobulin-resistant Kawasaki disease].
Liu F; Ding Y; Yin W
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Dec; 15(12):1109-12. PubMed ID: 24342209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
